GoodRx Holdings Inc. (Class A) (GDRX) carries a Roarable Rating of D+ (Sell) with 52/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)
FRED Regime × Technicals: 83% of 52W Range • RSI-14 at 52.3 (NEUTRAL RANGE)
Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)
While GDRX currently carries a cautious 52/100 (D+) rating due to Whale & Options Positioning (8/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Company leadership has skin in the game with net positive insider conviction.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.43) and Max Pain ($3.72) forces dealer call-delta covering toward $4.08.
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
GoodRx Holdings Inc. (Class A) (GDRX) surged +2.02% to $3.54, trading at 83% of its 52-week range ($1.77 – $3.89). Stretched risk/reward at 40x P/E (8% return on capital) under elevated 10-year interest-rate pressure.
GoodRx Holdings remains a 'buy' as shares are deeply undervalued despite recent operational headwinds and a 45% stock decline. Click to read more about GDRX.
SANTA MONICA, Calif., October 29, 2026--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced the market-wide launch of its Employer Direct weight loss offerin
GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today announced the market-wide launch of its Employer Direct weight loss offering, giving employers a flexible way to
Icon PLC (ICLR) delivered earnings and revenue surprises of +0.76% and +0.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Nvidia’s nearly US$10b push into European AI gives smaller, financially disciplined businesses fresh ways to plug into powerful tech without building it all themselves. That matters for low priced shares where every doll
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +0.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on GDRX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for GDRX. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, GoodRx Holdings Inc. (Class A) (GDRX) ranks #373 by composite RQD confidence (52/100, grade D+) and #340 by equity capitalization ($1.21B). Within this direct 5-issuer industry benchmark cohort, UPWK leads on earnings valuation at 9.9x trailing P/E, while LZ leads on capital efficiency and profitability with 34.7% ROIC and 65.9% gross margin. UPWK currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with GDRX at 52/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| GDRX
ACTIVE
GoodRx Holdings Inc. (Class A) | D+ | 52/100 | 39.7x | — | 8.3% | +2.02% | $1.21B | Benchmark Subject |
| UPWK Upwork Inc. | B- | 71/100 | 9.9x | 77.8% | 30.4% | +1.33% | $1.14B | /upwk-vs-gdrx → |
| LZ LegalZoom.com Inc. | C | 65/100 | 73.7x | 65.9% | 34.7% | +0.45% | $1.14B | /lz-vs-gdrx → |
| PSQL Pasqal Holding SA Ordinary Share | D | 47/100 | — | — | — | -5.07% | $1.11B | /psql-vs-gdrx → |
| CLVT Clarivate Plc | E | 33/100 | — | 66.0% | 1.3% | -2.27% | $1.10B | /clvt-vs-gdrx → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), GoodRx Holdings Inc. (Class A) (GDRX) reported GAAP revenue of $796.9M (+0.6% vs. FY2024 revenue of $792.3M , and +6.2% cumulative change since FY2023) , GAAP net income of $30.4M, operating cash flow of $167.9M, and free cash flow of $164.4M (-10.0% YoY). On the balance sheet, GDRX closed FY2025 with $1.40B in total assets against $483.3M in total debt (Altman Z-Score: 0.63, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $796.9M | $30.4M | $167.9M | $164.4M | $1.40B | $483.3M |
| FY2024 (FY) | 2024-12-31 | $792.3M | $16.4M | $183.9M | $182.7M | $1.39B | $486.7M |
| FY2023 (FY) | 2023-12-31 | $750.3M | -$8.9M | $138.3M | $138.3M | — | — |
As of 2026-11-01, GoodRx Holdings Inc. (Class A) (NASDAQ: GDRX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 52/100 at a spot price of $3.54 (+2.02% 1D, market cap $1.21B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 14/20. Across 714 tracked Technology issuers, GDRX ranks #373 in composite RQD confidence.
Within the Technology sector (EDP Services), GDRX carries a Roarable D+ (52/100 RQD), trailing P/E of 39.7x, gross margin of —, and ROIC of 8.3%. By comparison, UPWK (Upwork Inc.) holds a B- grade (71/100 RQD, P/E 9.9x, ROIC 30.4%, cap $1.14B) and LZ (LegalZoom.com Inc.) posts a C grade (65/100 RQD, P/E 73.7x, ROIC 34.7%, cap $1.14B). Among the 5-stock peer group, UPWK leads on earnings multiple (9.9x) while LZ leads on capital efficiency (34.7% ROIC).
Per GDRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001809519), GoodRx Holdings Inc. (Class A) generated $796.9M in revenue (+0.6% YoY), $30.4M in net income, and $164.4M in free cash flow against $1.40B in total assets and $483.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Priced at 40x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
GDRX last traded at $3.54 (+2.02% on volume of 1,437,123 shares), positioning the stock +3.21% above its 50-day simple moving average ($3.43) and +25.53% above its 200-day simple moving average ($2.82). Across its 52-week range of $1.77 to $3.89, GDRX sits at the 83.5% percentile with a 14-day RSI of 52.3 (NEUTRAL RANGE) and an implied next-earnings move of ±7.8% ($3.26 to $3.82).
Why GDRX Stock surged +2.02% Today — RQD Quant Desk Flash. Stretched risk/reward at 40x P/E (8% return on capital) under elevated 10-year interest-rate pressure.